Effect of methotrexate administration on status of some essential trace elements and antioxidant enzymes in pregnant rats in late gestation

Gynecological Endocrinology

Volumn 25, Issue 12, 2009, Pages 816-822

  Al Saleh, E ^a   Al Harmi, J ^a   Nandakumaran, M ^a   Al Shammari, M ^a   Al Jassar, W ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antioxidant enzymes; Cu; Methotrexate; Pregnant rats; Se; Zn

Indexed keywords

COPPER; GLUTATHIONE PEROXIDASE; METHOTREXATE; SELENIUM; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; ZINC;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD SAMPLING; BODY WEIGHT; BOLUS INJECTION; CONTROLLED STUDY; DECAPITATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; METABOLIC PARAMETERS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BLOOD CELL COUNT; BLOOD GLUCOSE; COPPER; FEMALE; FOLIC ACID ANTAGONISTS; GLUTATHIONE PEROXIDASE; METHOTREXATE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; SPECTROPHOTOMETRY, ATOMIC; SUPEROXIDE DISMUTASE; TRACE ELEMENTS; ZINC;

EID: 70450214434     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903056811     Document Type: Article

References (39)

1. Winter ME. Methotrexate. In: Winter ME, editor. Basal clinical pharmacokinetics, 2nd ed. Spokane, WA: Applied Therapeutics; 1988. pp 199-217.
2. Crom WR, Evans WE.Methotrexate. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics: Principles of therapeutic drug monitoring, 3rd ed. Spokane, WA: Applied Therapeutics; 1992. pp 29-43.
3. Orlando L, Cardillo A, Rocca A, Balduzzi A, Ghisini R, Perozzotti G, Goldhirsch A, D'alessandro C, Cinieri S, Preda L, et al. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer. Anticancer Drugs 2006;17:961-967.
4. Pels H, Schlegel U. Primary central nervous system lymphoma. Curr Treat Options Neurol 2006;8:346-357.
5. Franklin JL, Finlay J. Leukemias and lymphomas: Treatment and prophylaxis of the central nervous system. Curr Treat Options Neurol 2006;8:335-345.
6. Nakayama N, Koizumi W, Tanabe S, Sasaki T, Saigenji K. A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil and low-dose cisplatin(MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG 9501). Gastric Cancer 2006;9:185-191.
7. Shigehara K, Kitagawa Y, Nakashima T, Shimamura M. Squamous cell carcinoma of the baldder: A patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine. Int J Clin Oncol 2006;11:329-331.
8. Nash P. Alefacept plus methotrexate for psoriatic arthritis. Nat Clin Pract Rheumatol 2006;2:470-471.
9. Gray OM, McDonnell GV, Forbes RB. A systematic review of oral methotrexate for multiple sclerosis. Mult Scler 2006;12: 507-510.
10. McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20:1838-1844.
11. Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. Drugs 1994;47:25-50.
12. Alshimmiri MM, Al-Saleh E, Al-Harmi JA, Alsalili MB, Adwani AA, Ibrahim ME. Treatment of ectopic pregnancy with a single intramuscular dose of methotrexate. Arch Gynecol Obstet 2003;268:181-183.
13. Periti E, Comparetto C, Villanucci A, Coccia ME, Tavella K, Amunni G. The use of intravenous methotrexate in the treatment of ectopic pregnancy. J Chemother 2004;16:211-215.
14. Dalkalitsis N, Stefos T, Kaponis A, Tsanadis G, Paschopoulos M, Dousias V. Reproductive outcome in patients treated by oral methotrexate or laparoscopic salpingiotomy for the management of tubal ectopic pregnancy. Clin Exp Obstet Gynecol 2006;33:90-92.
15. Warkany J. Teratogenicity of folic acid antagonists. Cancer Bull 1981;33:76-77.
16. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 5th ed. Baltimore: Williams and Wilkins; 1998. pp 702-706.
17. Buckley LM, Bullaboy CA, Leichtman L, Marquet M. Multiple congenital anomalies associated with weekly lowdose methotrexate treatment of the mother. Arthritis Rheum 1997; 40:971-973.
18. Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. New Eng J Med 1987;317:1666-1667.
19. Milunsky A, Graef JW, Gaynor MF. Methotrexate-induced congenital malformations. J Peditar 1968;72:790-795.
20. Ostensen M, Hartmann H, Salvensen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 2000;27:1872-1875.
21. Rustin GJS, Booth M, Dent J, Salt S, Rustin F, Bagshawe KD. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. BMJ 1984;288:103-106.
22. Al-Saleh E, Al-Harmi J, Al-Rashdan I, Al-Shammari M, Nandakumaran M. Maternal-fetal transport kinetics of methotrexate in perfused human placenta: In vitro study. J Mat-Fet Neonat Med 2007;20:411-418. (Pubitemid 47221589)
23. Mertz W. The essential trace elements. Science 1981;213: 1332-1338.
24. Peerebom JWC. General aspects of trace elements and health. Sci Total Environ 1985;42:1-27.
25. Gibson RS. Assessment of trace element status in humans. Progr Nutr Sci 1989;13:67-111.
26. Oktem F, Yilmaz HR, Ozguner F, Olgar S, Avata A, Uzare E, Uz E. Mtehotrexate-induced renal oxidative stress in rats: The role of a novel antioxidant caffeic acid phenethyl ester. Toxicol Ind Health 2006;22:241-247.
27. Cetiner M, Sener G, Schirli AO, Eksioglu-Demiralp E, Ercan F, Sirvanci S, Gedik N, Akpulat S, Tecimer T, Yegen BC. Taurine protects against methotrexate-induced toxicity and inhibits leucocyte death. Toxicol Appl Pharmacol 2005;209: 39-50.
28. Devrim E, Cetim R, Klicoglu B, Erguder BI, Avci A, Durak I. Methotrexate causes oxidative stress in rat kidney tissues. Ren Fail 2005;27:771-773.
29. Vernie IN, De Vries M, Benckhuijsen C, De Goeij JJ, Zegers C. Selenium levels in blood and plasma and glutathione peroxidase activity in blood of breast cancer patients during adjuvant treatment with cyclophosphamide, methotrexate and 5-fluorouracil. Cancer Lett 1983;18:283-289.
30. Huang CC, Hsu PC, Hung YC, Liao YF, Liu CC, Hour CT, Kao MC, Tsay GJ, Hung HC, Liu GY. Orntihine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production. Apoptosis 2005;10:895-907.
31. Cetinkaya A, Bulbuloglu E, Kurutas EB, Kantarceken B. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med Sci Monit 2006;12:274-278.
32. Helmy M, Shohayeb M, Helmy MH, el-Bassiouni EA. Antioxidants as adjuvant therapy in rheumatoid disease. A preliminary study. Arzneimittelforschung 2001;51:293-298.
33. Brock S, Jennings HR. Fetal acute encephalomyelitis after a single dose of intrathecal methotrexate. Pharmacotherapy 2004;24:673-676.
34. Valik D, Sterba J, Bajciova V, Demlova R. Severe encephalopathy induced by the first but not the second course of high dose methotrexate mirrored by plasma homocysteine evaluations and preceded by extreme differences in pretreatment plasma folate. Oncology 2005;69:269-272.
35. Khan F, Everard J, Ahmed S, Coleman RE, Aitken M, Hancock BW. Low-risk persietent gestational trophoblastic disease treated with low-dose methotrexate: Efficacy, acute and long-term effects. Br J Cancer 2003;89:2197-12101
36. Troche G, Sacquin P, Achkar A, Korach JM, Laaban JP, Gajdos P. Severe methotrexate poisoning. Presse Med 1991;20:1724-1727.
37. Chatham WW, Morgan SL, Alarcon GS. Renal failure: A risk factor for methotrexate toxicity. Arthritis Rheum 2000;43: 1185-1186.
38. Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer 1995;76:521-526.
39. Sieber SM, Adamson RH. Toxicity of antineoplastic agents in man: chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential. Adv Cancer Res 1975;22:57-155.